Science Explorer Back to mapMap
Discussion
Company · Solna · Sweden

Affibody (Sweden)

affibody.seROR OpenAlex
Research works
58
▲ 139% vs 2018-21
Citations
3.8k
65.6 per fractional work
Top-10% rate
17.6%
all institutions 10.0%
Open access
50%
world 40%
International
33%
world 18%
Affibody (Sweden)

Not ranked overall: Affibody (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Affibody (Sweden) work in?

In all years, 65% of research at Affibody (Sweden) is in Health Sciences, 30% in Life Sciences. Its largest fields are Medicine (65%), Biochemistry, Genetics and Molecular Biology (26%), Immunology and Microbiology (3%). It does 2.5× the world's share of Health Sciences.

Health Sciences: 38 fractional works · 64.7% of its workMedicine: 38 fractional works · 64.7% of its workRadiology, Nuclear Medicine and Imaging: 25 fractional works · 42.8% of its workOncology: 7 fractional works · 12.6% of its workGenetics: 1 fractional works · 1.5% of its workPulmonary and Respiratory Medicine: 1 fractional works · 1.5% of its workPathology and Forensic Medicine: 1 fractional works · 1.0% of its workEpidemiology: 1 fractional works · 1.0% of its workSurgery: 0 fractional works · 0.8% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.7% of its workPhysiology: 0 fractional works · 0.7% of its workHepatology: 0 fractional works · 0.6% of its workNeurology: 0 fractional works · 0.6% of its workHematology: 0 fractional works · 0.3% of its workObstetrics and Gynecology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.5% of its workNursing: 0 fractional works · 0.1% of its workLife Sciences: 18 fractional works · 30.2% of its workBiochemistry, Genetics and Molecular Biology: 15 fractional works · 25.5% of its workMolecular Biology: 11 fractional works · 18.9% of its workBiotechnology: 2 fractional works · 2.6% of its workCell Biology: 1 fractional works · 1.6% of its workEndocrinology: 0 fractional works · 0.8% of its workCancer Research: 0 fractional works · 0.7% of its workGenetics: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.3% of its workImmunology and Microbiology: 2 fractional works · 3.4% of its workImmunology: 2 fractional works · 3.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 1.0% of its workPharmaceutical Science: 1 fractional works · 1.0% of its workNeuroscience: 0 fractional works · 0.2% of its workPhysical Sciences: 3 fractional works · 5.1% of its workEngineering: 1 fractional works · 2.3% of its workBiomedical Engineering: 1 fractional works · 1.7% of its workElectrical and Electronic Engineering: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEnvironmental Science: 1 fractional works · 1.3% of its workEcology: 1 fractional works · 0.9% of its workNature and Landscape Conservation: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 0 fractional works · 0.8% of its workBiomaterials: 0 fractional works · 0.4% of its workMaterials Chemistry: 0 fractional works · 0.4% of its workChemistry: 0 fractional works · 0.7% of its workSpectroscopy: 0 fractional works · 0.4% of its workOrganic Chemistry: 0 fractional works · 0.3% of its workComputer Science: 0 fractional works · 0.1% of its workALL ITS WORKAffibody (Sweden)58fractional works, all years
Life Sciences30%Physical Sciences5%Health Sciences65%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 11 fields, with their numbers
    1. Medicine3864.7%
    2. Nursing00.1%
    1. Biochemistry, Genetics and Molecular Biology1525.5%
    2. Immunology and Microbiology23.4%
    3. Pharmacology, Toxicology and Pharmaceutics11.0%
    4. Neuroscience00.2%
    1. Engineering12.3%
    2. Environmental Science11.3%
    3. Materials Science00.8%
    4. Chemistry00.7%
    5. Computer Science00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 2.31× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 6.82× its world share, 1 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 5.96× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.65× its world share, 0 worksChemistryEngineering: 0.19× its world share, 0 worksEngineeringMaterials Science: 0.53× its world share, 0 worksMaterials ScienceMedicine: 3.80× its world share, 9 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.8×. Every wedge is a field page.

All 7 fields, with their numbers
  1. Immunology and Microbiology6.82×1 works
  2. Pharmacology, Toxicology and Pharmaceutics5.96×0 works
  3. Medicine3.80×9 works
  4. Biochemistry, Genetics and Molecular Biology2.31×2 works
  5. Chemistry0.65×0 works
  6. Materials Science0.53×0 works
  7. Engineering0.19×0 works

Who are the top researchers at Affibody (Sweden)?

Ranked on the quality score, Joachim Feldwisch, Fredrik Y. Nilsson and Ingmarie Höidén‐Guthenberg lead among researchers whose main affiliation is Affibody (Sweden).

  1. 1 Joachim Feldwisch Sweden · #327,681 worldwide 4.3k citations · 103 works
  2. 2 Fredrik Y. Nilsson Sweden · #735,537 worldwide 3.1k citations · 50 works
  3. 3 Ingmarie Höidén‐Guthenberg Sweden · #1,323,888 worldwide 1.7k citations · 21 works
All ranked researchers at Affibody (Sweden)

What are the most cited papers from Affibody (Sweden)?

The most cited paper from Affibody (Sweden) is "Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications" (John Löfblom, Joachim Feldwisch, Vladimir Tolmachev et al., 2010), with 657 citations. Next come "Tumor Imaging Using a Picomolar Affinity HER2 Binding Affibody Molecule" (574) and "Protein A chromatography for antibody purification" (561).

Most cited papers
#PaperReleasedCitations
1 Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications John Löfblom, Joachim Feldwisch, Vladimir Tolmachev et al. · FEBS Letters Open access 11 Apr 2010 657
2 Tumor Imaging Using a Picomolar Affinity HER2 Binding Affibody Molecule Anna Orlova, Mikaela Magnusson, Tove Lisa Jenny Eriksson et al. · Cancer Research Open access 15 Apr 2006 574
3 Protein A chromatography for antibody purification Sophia Hober, Karin Nord, Martin Linhult · Journal of Chromatography B 10 Oct 2006 561
4 Stabilization of a β-hairpin in monomeric Alzheimer's amyloid-β peptide inhibits amyloid formation Wolfgang Hoyer, Caroline Grönwall, Andreas Jonsson et al. · Proceedings of the National Academy of Sciences Open access 29 Mar 2008 418
5 Affibody Molecules in Biotechnological and Medical Applications Stefan Ståhl, Torbjörn Gräslund, Amelie Eriksson Karlström et al. · Trends in biotechnology Review 14 May 2017 394
All 61 most cited papers, with filters and sorting

Which keywords describe research at Affibody (Sweden)?

By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, PET Imaging, Targeted Therapy and Cancer Treatment.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 38 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 38 words, with their numbers
  1. Glycosylation21▲ 166×3 topics
  2. Monoclonal Antibodies17▲ 203×3 topics
  3. Therapeutic Antibodies17▲ 225×2 topics
  4. Antibody Engineering16▲ 269×1 topic
  5. Fc Receptors16▲ 269×1 topic
  6. PET Imaging9▲ 75×3 topics
  7. Targeted Therapy9▲ 72×4 topics
  8. Cancer Treatment8▲ 57×2 topics
  9. Radioimmunotherapy8▲ 363×1 topic
  10. Radiopharmaceuticals8▲ 363×1 topic
  11. Cancer7▲ 9.0×9 topics
  12. Chemotherapy6▲ 14×4 topics
  13. Monoclonal Antibody6▲ 139×2 topics
  14. Immune System6▲ 29×2 topics
  15. Breast Cancer5▲ 33×2 topics
  16. Glycans5▲ 115×1 topic
  17. Mucins5▲ 115×1 topic
  18. HER25▲ 302×1 topic
  19. Trastuzumab5▲ 214×1 topic
  20. Immunotherapy3▲ 9.0×8 topics
  21. Nanoparticles2▲ 3.1×6 topics
  22. Tumor Targeting2▲ 26×3 topics
  23. Biopharmaceuticals2▲ 42×3 topics
  24. Cancer Therapy2▲ 4.5×6 topics
  25. Tumor Regression2▲ 34×2 topics
  26. Gene Therapy2▲ 11×4 topics
  27. Recombinant Proteins2▲ 48×2 topics
  28. Immunogenicity1▲ 46×2 topics
  29. Arginine Deprivation1▲ 45×1 topic
  30. Bacterial Therapy1▲ 45×1 topic
  31. Lymphoma1▲ 14×2 topics
  32. Oxidative Stress1◆ 1.13×8 topics
  33. Protein Aggregation1▲ 27×1 topic
  34. Rituximab1▲ 13×2 topics
  35. Stability1▲ 11×1 topic
  36. Tumor Microenvironment1▲ 5.9×4 topics
  37. Imaging1▲ 5.2×2 topics
  38. Prognostic Factors1▲ 3.9×3 topics

Which research topics does Affibody (Sweden) publish most on?

By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, Radiopharmaceutical Chemistry and Applications, HER2/EGFR in Cancer Research and CAR-T cell therapy research.

Monoclonal and Polyclona…3Monoclonal and Polyclonal Antibodies Research: 3 fractional worksRadiopharmaceutical Chem…2Radiopharmaceutical Chemistry and Applications: 2 fractional worksHER2/EGFR in Cancer Rese…1HER2/EGFR in Cancer Research: 1 fractional worksCAR-T cell therapy research: 0 fractional worksMedical Imaging Techniques and Applications: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksGlycosylation and Glycoproteins Research: 0 fractional worksAdvanced biosensing and bioanalysis techniques: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksTransgenic Plants and Applications: 0 fractional works
Radiology, Nuclear Medicine and ImagingOncologyMolecular BiologyImmunology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
  2. 2 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 2 works
  3. 3 HER2/EGFR in Cancer Research Oncology 1 works
  4. 4 CAR-T cell therapy research Oncology 0 works
  5. 5 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
  6. 6 Cancer Immunotherapy and Biomarkers Oncology 0 works
  7. 7 Glycosylation and Glycoproteins Research Molecular Biology 0 works
  8. 8 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
  9. 9 Immunotherapy and Immune Responses Immunology 0 works
  10. 10 Transgenic Plants and Applications Biotechnology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.4%not open49.6%

World: 40% of research is openly available.

with international co-authors33.1%domestic only66.9%

World: 18% is written across borders.

How has Affibody (Sweden)'s research output changed?

Output in 2022-2025 was 139% higher than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Affibody (Sweden) as a percentage of every work published that year, 0.000058% in 2024.

still counting0.00010%0.00020%0.00030%Affibody (Sweden)0.000035% in 202520102020

Fractional works of Affibody (Sweden) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Solna

All research institutions in Solna

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Affibody (Sweden). Posts are plain text and can be reported.